| Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ... New England Journal of Medicine 379 (2), 111-121, 2018 | 2286 | 2018 |
| MONARCH 3: abemaciclib as initial therapy for advanced breast cancer MP Goetz, M Toi, M Campone, J Sohn, S Paluch-Shimon, J Huober, ... Journal of Clinical Oncology 35 (32), 3638-3646, 2017 | 1716 | 2017 |
| Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes MP Goetz, JM Rae, VJ Suman, SL Safgren, MM Ames, DW Visscher, ... Journal of Clinical Oncology 23 (36), 9312-9318, 2005 | 999 | 2005 |
| Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology WJ Gradishar, BO Anderson, J Abraham, R Aft, D Agnese, KH Allison, ... Journal of the National Comprehensive Cancer Network 18 (4), 452-478, 2020 | 857 | 2020 |
| Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology WJ Gradishar, MS Moran, J Abraham, R Aft, D Agnese, KH Allison, ... Journal of the National Comprehensive Cancer Network 20 (6), 691-722, 2022 | 746 | 2022 |
| The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen MP Goetz, SK Knox, VJ Suman, JM Rae, SL Safgren, MM Ames, ... Breast cancer research and treatment 101, 113-121, 2007 | 709 | 2007 |
| Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study MP Goetz, MR Callstrom, JW Charboneau, MA Farrell, TP Maus, TJ Welch, ... Journal of Clinical Oncology 22 (2), 300-306, 2004 | 707 | 2004 |
| Tailoring adjuvant endocrine therapy for premenopausal breast cancer PA Francis, O Pagani, GF Fleming, BA Walley, M Colleoni, I Láng, ... New England Journal of Medicine 379 (2), 122-137, 2018 | 699 | 2018 |
| Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen W Schroth, MP Goetz, U Hamann, PA Fasching, M Schmidt, S Winter, ... Jama 302 (13), 1429-1436, 2009 | 670 | 2009 |
| MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer S Johnston, M Martin, A Di Leo, SA Im, A Awada, T Forrester, M Frenzel, ... NPJ breast cancer 5 (1), 5, 2019 | 581 | 2019 |
| NCCN guidelines insights: breast cancer, version 1.2017 WJ Gradishar, BO Anderson, R Balassanian, SL Blair, HJ Burstein, A Cyr, ... Journal of the national comprehensive cancer network 15 (4), 433-451, 2017 | 495 | 2017 |
| Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer JA Sparano, RJ Gray, PM Ravdin, DF Makower, KI Pritchard, KS Albain, ... New England journal of medicine 380 (25), 2395-2405, 2019 | 493 | 2019 |
| The Hsp90 chaperone complex as a novel target for cancer therapy MP Goetz, DO Toft, MM Ames, C Erlichman Annals of oncology 14 (8), 1169-1176, 2003 | 461 | 2003 |
| Use of biomarkers to guide decisions on systemic therapy for women with metastatic breast cancer: American Society of Clinical Oncology clinical practice guideline C Van Poznak, MR Somerfield, RC Bast, M Cristofanilli, MP Goetz, ... Journal of clinical oncology 33 (24), 2695-2704, 2015 | 459 | 2015 |
| Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging R Katipamula, AC Degnim, T Hoskin, JC Boughey, C Loprinzi, CS Grant, ... Journal of Clinical Oncology 27 (25), 4082-4088, 2009 | 444 | 2009 |
| Breast cancer, version 4.2017, NCCN clinical practice guidelines in oncology WJ Gradishar, BO Anderson, R Balassanian, SL Blair, HJ Burstein, A Cyr, ... Journal of the National Comprehensive Cancer Network 16 (3), 310-320, 2018 | 407 | 2018 |
| Invasive breast cancer version 1.2016, NCCN clinical practice guidelines in oncology WJ Gradishar, BO Anderson, R Balassanian, SL Blair, HJ Burstein, A Cyr, ... Journal of the National Comprehensive Cancer Network 14 (3), 324-354, 2016 | 387 | 2016 |
| Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer MP Goetz, D Toft, J Reid, M Ames, B Stensgard, S Safgren, AA Adjei, ... Journal of clinical oncology 23 (6), 1078-1087, 2005 | 385 | 2005 |
| Painful metastases involving bone: feasibility of percutaneous CT-and US-guided radio-frequency ablation MR Callstrom, JW Charboneau, MP Goetz, J Rubin, GY Wong, JA Sloan, ... Radiology 224 (1), 87-97, 2002 | 375 | 2002 |
| Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim … SRD Johnston, M Toi, J O'Shaughnessy, P Rastogi, M Campone, ... The Lancet Oncology 24 (1), 77-90, 2023 | 355 | 2023 |
Krishna Rani KalariAssociate Professor, Mayo ClinicEmail yang diverifikasi di mayo.edu
